Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883819264> ?p ?o ?g. }
- W2883819264 endingPage "285.e6" @default.
- W2883819264 startingPage "279" @default.
- W2883819264 abstract "Background Early hospital readmissions for asthma and chronic obstructive pulmonary disease (COPD), measured as hospital readmission within 30 days from the last discharge, is a major economic burden to our health care system. The association of this measure with comorbid chronic rhinitis (CR) has not been investigated before despite significant clinical association between CR and asthma or COPD. Objective To investigate the association of CR with the risk of asthma or COPD-related early hospital readmission rates. Methods This retrospective cohort study was performed using the asthma- and COPD-related hospital encounter and patient comorbidity data between June 15, 2012, and July 19, 2017, from a large hospital care system in Cincinnati, Ohio. Patients (any sex, race or socioeconomic status, and of all ages) with a primary discharge diagnosis of asthma (n = 4754 patients, 10,111 encounters) and COPD (n = 2176 patients, 4748 encounters) based on International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes were included. Relevant comorbidities, including comorbid allergic rhinitis (AR) or nonallergic rhinitis (NAR), in such patients were identified using ICD-10-CM codes. The association between 30-day asthma or COPD-related hospital readmission (1670 such encounters for asthma and 736 for COPD) and comorbid CR in the affected patients were determined using Cox proportional hazards models. Multivariate-adjusted hazard ratios (HRs), adjusted for relevant patient comorbidities, compared 30-day asthma- and COPD-related readmissions of patients with CR with those patients without a CR diagnosis. Results Analysis was performed on 4754 patients with asthma and 2176 patients with COPD. The median follow-up period (+interquartile range) for asthma was 980 (+760) days and for COPD was 553 (+827) days. The HRs for 30-day asthma- or COPD-related readmission rates were significantly higher in patients with AR (HR = 4.4 [3.9, 5.0] and 2.4 [1.7, 3.2], respectively) or NAR (HR = 3.7 [2.9, 4.9] and 2.6 [1.8, 3.7], respectively) compared with patients without rhinitis. For asthma, both AR and NAR had higher HRs compared with all other comorbidities analyzed. For COPD, both AR and NAR had HRs to the magnitude as obesity and hypertension. Conclusions Comorbid CR is significantly associated with 30-day asthma- and COPD-related readmissions. These findings are useful for guiding health care professionals to focus on outpatient management of both the upper and lower respiratory tracts to reduce early readmission of patients with asthma and COPD. Early hospital readmissions for asthma and chronic obstructive pulmonary disease (COPD), measured as hospital readmission within 30 days from the last discharge, is a major economic burden to our health care system. The association of this measure with comorbid chronic rhinitis (CR) has not been investigated before despite significant clinical association between CR and asthma or COPD. To investigate the association of CR with the risk of asthma or COPD-related early hospital readmission rates. This retrospective cohort study was performed using the asthma- and COPD-related hospital encounter and patient comorbidity data between June 15, 2012, and July 19, 2017, from a large hospital care system in Cincinnati, Ohio. Patients (any sex, race or socioeconomic status, and of all ages) with a primary discharge diagnosis of asthma (n = 4754 patients, 10,111 encounters) and COPD (n = 2176 patients, 4748 encounters) based on International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes were included. Relevant comorbidities, including comorbid allergic rhinitis (AR) or nonallergic rhinitis (NAR), in such patients were identified using ICD-10-CM codes. The association between 30-day asthma or COPD-related hospital readmission (1670 such encounters for asthma and 736 for COPD) and comorbid CR in the affected patients were determined using Cox proportional hazards models. Multivariate-adjusted hazard ratios (HRs), adjusted for relevant patient comorbidities, compared 30-day asthma- and COPD-related readmissions of patients with CR with those patients without a CR diagnosis. Analysis was performed on 4754 patients with asthma and 2176 patients with COPD. The median follow-up period (+interquartile range) for asthma was 980 (+760) days and for COPD was 553 (+827) days. The HRs for 30-day asthma- or COPD-related readmission rates were significantly higher in patients with AR (HR = 4.4 [3.9, 5.0] and 2.4 [1.7, 3.2], respectively) or NAR (HR = 3.7 [2.9, 4.9] and 2.6 [1.8, 3.7], respectively) compared with patients without rhinitis. For asthma, both AR and NAR had higher HRs compared with all other comorbidities analyzed. For COPD, both AR and NAR had HRs to the magnitude as obesity and hypertension. Comorbid CR is significantly associated with 30-day asthma- and COPD-related readmissions. These findings are useful for guiding health care professionals to focus on outpatient management of both the upper and lower respiratory tracts to reduce early readmission of patients with asthma and COPD." @default.
- W2883819264 created "2018-08-03" @default.
- W2883819264 creator A5002409424 @default.
- W2883819264 creator A5023747136 @default.
- W2883819264 creator A5038654593 @default.
- W2883819264 date "2019-01-01" @default.
- W2883819264 modified "2023-09-26" @default.
- W2883819264 title "Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease" @default.
- W2883819264 cites W1757801909 @default.
- W2883819264 cites W1968623591 @default.
- W2883819264 cites W1976268445 @default.
- W2883819264 cites W2004689238 @default.
- W2883819264 cites W2075870230 @default.
- W2883819264 cites W2088440049 @default.
- W2883819264 cites W2092810409 @default.
- W2883819264 cites W2097548575 @default.
- W2883819264 cites W2141479546 @default.
- W2883819264 cites W2168240871 @default.
- W2883819264 cites W2265146967 @default.
- W2883819264 cites W2318425013 @default.
- W2883819264 cites W2323032829 @default.
- W2883819264 cites W2409013167 @default.
- W2883819264 cites W2470573573 @default.
- W2883819264 cites W2549700450 @default.
- W2883819264 cites W2550642549 @default.
- W2883819264 cites W2599511161 @default.
- W2883819264 cites W2601652410 @default.
- W2883819264 cites W2621582163 @default.
- W2883819264 cites W2755839178 @default.
- W2883819264 cites W2758329262 @default.
- W2883819264 cites W2761313519 @default.
- W2883819264 cites W2761823135 @default.
- W2883819264 cites W2764074664 @default.
- W2883819264 cites W2765256236 @default.
- W2883819264 cites W2766533706 @default.
- W2883819264 cites W2769396190 @default.
- W2883819264 doi "https://doi.org/10.1016/j.jaip.2018.06.029" @default.
- W2883819264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30053594" @default.
- W2883819264 hasPublicationYear "2019" @default.
- W2883819264 type Work @default.
- W2883819264 sameAs 2883819264 @default.
- W2883819264 citedByCount "16" @default.
- W2883819264 countsByYear W28838192642019 @default.
- W2883819264 countsByYear W28838192642020 @default.
- W2883819264 countsByYear W28838192642021 @default.
- W2883819264 countsByYear W28838192642022 @default.
- W2883819264 countsByYear W28838192642023 @default.
- W2883819264 crossrefType "journal-article" @default.
- W2883819264 hasAuthorship W2883819264A5002409424 @default.
- W2883819264 hasAuthorship W2883819264A5023747136 @default.
- W2883819264 hasAuthorship W2883819264A5038654593 @default.
- W2883819264 hasConcept C126322002 @default.
- W2883819264 hasConcept C167135981 @default.
- W2883819264 hasConcept C1862650 @default.
- W2883819264 hasConcept C207103383 @default.
- W2883819264 hasConcept C2776042228 @default.
- W2883819264 hasConcept C2776780178 @default.
- W2883819264 hasConcept C2779159551 @default.
- W2883819264 hasConcept C2908647359 @default.
- W2883819264 hasConcept C44249647 @default.
- W2883819264 hasConcept C45827449 @default.
- W2883819264 hasConcept C50382708 @default.
- W2883819264 hasConcept C71924100 @default.
- W2883819264 hasConcept C72563966 @default.
- W2883819264 hasConcept C99454951 @default.
- W2883819264 hasConceptScore W2883819264C126322002 @default.
- W2883819264 hasConceptScore W2883819264C167135981 @default.
- W2883819264 hasConceptScore W2883819264C1862650 @default.
- W2883819264 hasConceptScore W2883819264C207103383 @default.
- W2883819264 hasConceptScore W2883819264C2776042228 @default.
- W2883819264 hasConceptScore W2883819264C2776780178 @default.
- W2883819264 hasConceptScore W2883819264C2779159551 @default.
- W2883819264 hasConceptScore W2883819264C2908647359 @default.
- W2883819264 hasConceptScore W2883819264C44249647 @default.
- W2883819264 hasConceptScore W2883819264C45827449 @default.
- W2883819264 hasConceptScore W2883819264C50382708 @default.
- W2883819264 hasConceptScore W2883819264C71924100 @default.
- W2883819264 hasConceptScore W2883819264C72563966 @default.
- W2883819264 hasConceptScore W2883819264C99454951 @default.
- W2883819264 hasIssue "1" @default.
- W2883819264 hasLocation W28838192641 @default.
- W2883819264 hasLocation W28838192642 @default.
- W2883819264 hasOpenAccess W2883819264 @default.
- W2883819264 hasPrimaryLocation W28838192641 @default.
- W2883819264 hasRelatedWork W1982761825 @default.
- W2883819264 hasRelatedWork W2068946269 @default.
- W2883819264 hasRelatedWork W2098483241 @default.
- W2883819264 hasRelatedWork W2396486386 @default.
- W2883819264 hasRelatedWork W2568635802 @default.
- W2883819264 hasRelatedWork W2570885418 @default.
- W2883819264 hasRelatedWork W2942922422 @default.
- W2883819264 hasRelatedWork W2980864243 @default.
- W2883819264 hasRelatedWork W4367146082 @default.
- W2883819264 hasRelatedWork W4367146385 @default.
- W2883819264 hasVolume "7" @default.
- W2883819264 isParatext "false" @default.
- W2883819264 isRetracted "false" @default.
- W2883819264 magId "2883819264" @default.